RxDoctor Payments Data

Shellie Marthini

Gerontology · Richland, WANPI 1790313419

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 90 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by AstraZeneca at 30.3% of the total.

$2,334in general payments, 2019–2025

Across 90 payments — averaging $25.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$708
  • Boehringer Ingelheim$241
  • GSK$192
  • AbbVie$189
  • Phathom Pharmaceuticals, Inc.$157
  • Johnson & Johnson$139
  • plus $707 from 12 others

What the payments were for

  • Food & beverage$2,334100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,334 in reported general payments places this provider in the 85th percentile of 105 gerontology providers in Washington.

See all gerontology providers in Washington

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter70$50,956
JardianceEmpagliflozin35$46,321
FarxigaDapagliflozin Propanediol29$27,717
EliquisApixaban24$21,288
XareltoRivaroxaban17$17,363
Levothyroxine Sodium240$1,649
Albuterol Sulfate HfaAlbuterol Sulfate63$1,182
Ezetimibe67$933
Losartan Potassium144$908
Omeprazole61$902
SynthroidLevothyroxine Sodium11$863
Atorvastatin Calcium104$780
Pantoprazole Sodium59$708
Amlodipine Besylate109$665
Potassium Chloride50$658

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta$192$50,95670 claims
Boehringer IngelheimJardiance$241$46,32135 claims
AstraZenecaFarxiga$708$27,71729 claims
Johnson & JohnsonXarelto$139$17,36317 claims
AbbVieSynthroid$189$86311 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 105 gerontology providers in Washington.

Other gerontology in Richland

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →